Stock Price Movement and Market Context
On 28 Jan 2026, Medi Caps Ltd’s share price touched Rs.27.51, the lowest level in the past year, reflecting a cumulative decline of 41.14% over the last 12 months. This contrasts sharply with the broader Sensex index, which has appreciated by 8.22% during the same period. The stock’s 52-week high was Rs.53.76, underscoring the extent of the downward trajectory.
Despite the recent dip, the stock outperformed its sector by 1.48% today and showed a modest recovery after two consecutive days of decline. However, it remains below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating persistent downward pressure.
The broader market environment showed resilience, with the Sensex rising 244.98 points (0.34%) to close at 82,137.34, just 4.9% shy of its 52-week high of 86,159.02. Mega-cap stocks led the gains, while the Sensex traded below its 50-day moving average, which itself remains above the 200-day moving average, signalling a mixed but generally positive market tone.
Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.
- - Investment Committee approved
- - 50+ candidates screened
- - Strong post-announcement performance
Financial Performance and Profitability Metrics
Medi Caps Ltd’s financial results have been under pressure, contributing to the stock’s subdued performance. The company reported net sales of Rs.11.68 crores for the nine months ended September 2025, representing a decline of 47.76% compared to the previous period. This contraction in revenue has weighed heavily on profitability.
The quarterly profit after tax (PAT) stood at a loss of Rs.1.82 crores, a deterioration of 107.4% relative to the average of the preceding four quarters. This negative PAT underscores the challenges faced in generating earnings from operations.
Cash and cash equivalents were reported at a low Rs.0.09 crores at the half-year mark, indicating limited liquidity buffers. The company’s earnings before interest and taxes (EBIT) to interest ratio averaged -1.38, reflecting difficulties in servicing debt obligations effectively.
Return on equity (ROE) averaged a modest 1.46%, signalling low profitability relative to shareholders’ funds. These metrics collectively point to weak long-term fundamental strength, which has influenced the stock’s grading.
Stock Grading and Risk Assessment
MarketsMOJO assigns Medi Caps Ltd a Mojo Score of 3.0 with a current Mojo Grade of Strong Sell, upgraded from Sell on 1 Feb 2025. The market capitalisation grade stands at 4, indicating a micro-cap status with associated risks.
The stock’s valuation is considered risky relative to its historical averages, with profits declining by 278.5% over the past year. The consistent underperformance against the BSE500 benchmark over the last three annual periods further highlights the challenges faced by the company in delivering shareholder value.
Despite the recent slight uptick in price after two days of falls, the overall trend remains negative, with the stock trading below all major moving averages and continuing to lag sector peers.
Medi Caps Ltd or something better? Our SwitchER feature analyzes this micro-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Shareholding and Sector Positioning
The majority shareholding in Medi Caps Ltd remains with the promoters, maintaining control over corporate decisions. The company operates within the Pharmaceuticals & Biotechnology sector, which has seen varied performance across constituents, with larger-cap peers generally outperforming smaller micro-cap stocks like Medi Caps.
While the Sensex and mega-cap stocks have shown resilience and gains, Medi Caps Ltd’s stock has not mirrored this trend, reflecting company-specific factors impacting its valuation and market sentiment.
Summary of Key Metrics
To summarise, Medi Caps Ltd’s stock has declined to Rs.27.51, its lowest in 52 weeks, with a one-year return of -41.14%. The company’s financials reveal a significant contraction in sales and a widening net loss, alongside limited cash reserves and a negative EBIT to interest coverage ratio. The Mojo Grade of Strong Sell reflects these fundamental weaknesses, while the stock’s trading below all major moving averages indicates ongoing downward momentum.
In contrast, the Sensex has gained 8.22% over the same period, highlighting the stock’s relative underperformance. The company’s promoter holding remains intact, but the challenges in profitability and liquidity continue to weigh on the stock’s market standing.
Unlock special upgrade rates for a limited period. Start Saving Now →
